Difesa Capital Management’s SeaStar Medical ICU Stock Holding History

Difesa Capital Management’s Portfolio ICU Stock Details ICU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-63	Closed	-$163K	–	247
2022 Q3	$163K	Hold	63	–	–	0.08%	98
2022 Q2	$161K	Hold	63	–	–	0.09%	102
2022 Q1	$160K	Hold	63	–	–	0.08%	123
2021 Q4	$159K	Buy	+63	New	+$158K	0.11%	118

Other funds holding ICU

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

CCFM

Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return

SWA

SFMG Wealth Advisors Plano, Texas $1.48B AUM 15.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Difesa Capital Management's ICU Position: Q4 2022 in Review

Difesa Capital Management sold out of SeaStar Medical (ICU) in Q4 2022, closing a stake of 63 shares — an estimated $163K sold.

Difesa Capital Management first reported a position in ICU in Q4 2021 and held it in 4 quarters. The position peaked at $163K in Q3 2022. 8 funds tracked by Wall St. Rank hold ICU as of Q4 2022.

Difesa Capital Management reported no remaining SeaStar Medical position as of Q4 2022 after selling out during the quarter.
Difesa Capital Management sold 63 SeaStar Medical shares in Q4 2022, an estimated $163K.
Difesa Capital Management first reported a position in SeaStar Medical in Q4 2021 and held it in 4 quarters.
Difesa Capital Management's SeaStar Medical position peaked at $163K in Q3 2022.
8 funds tracked by Wall St. Rank held SeaStar Medical as of Q4 2022.

Based on Difesa Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.